Fisher Asset Management LLC Trims Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Fisher Asset Management LLC cut its position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 2.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,352,244 shares of the company’s stock after selling 88,758 shares during the period. Fisher Asset Management LLC owned about 0.33% of iShares U.S. Pharmaceuticals ETF worth $236,702,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of IHE. Cultivar Capital Inc. purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the second quarter worth $25,000. Rothschild Investment LLC purchased a new position in iShares U.S. Pharmaceuticals ETF during the second quarter valued at $26,000. US Bancorp DE grew its stake in iShares U.S. Pharmaceuticals ETF by 137.0% during the third quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after acquiring an additional 222 shares in the last quarter. Mather Group LLC. purchased a new position in iShares U.S. Pharmaceuticals ETF during the second quarter valued at $29,000. Finally, Assetmark Inc. grew its stake in iShares U.S. Pharmaceuticals ETF by 100.0% during the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock valued at $31,000 after acquiring an additional 216 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

IHE opened at $68.46 on Tuesday. The stock has a market capitalization of $691.40 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. The company has a fifty day moving average of $70.04 and a 200 day moving average of $68.77. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $57.96 and a fifty-two week high of $72.94.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.